AAO-HNS GUIDELINES Bundle (free trial)

Epistaxis (Nosebleed)

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1197258

Contents of this Issue

Navigation

Page 11 of 21

12 Treatment Figure 5. Epistaxis Guideline Key Action Statements KAS1 Nasal Compression NO KAS2 NO KAS6 Option of 1 or More of Following: • Topical Vasoconstrictors • Lubricants • Nasal Cautery Patient with Nosebleed Anterior Rhinoscopy with or without Nasal Endoscopy YES Needs Prompt Management? YES Bleeding Controlled? NO YES Active Bleeding? KAS8 Risk Factor Assessment KAS5 Assess for HHT If Recurrent Bilateral Bleeds and Family Hx of Nosebleeds KAS12 Anterior Rhinoscopy with or without Nasal Endoscopy KAS6, KAS7A, KAS7B Bleeding Site Identified? YES Suspected Bleeding Disorder, HHT, or on Anticoagulants? NO Non-Absorbable or Absorbable Packing Absorbable Packing YES NO Nasal Packing Education KAS4 Anesthetize Bleeding Site and Limit Nasal Cautery to Site KAS9 Bleeding Controlled? NO Is Patient on Anti-coagulants or Anti-Platelet Medications? Life- Threatening Nasal Bleeding? KAS11 NO NO YES YES Assess Need for and Risks of Reversal or Discontinuation of Anti- Coag/Anti-Platelet Medications YES KAS3A, KAS3B

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Epistaxis (Nosebleed)